Clinical trials
Observational trials in Qatar
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
97 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2008 | 2 |
| 2009 | 4 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 4 |
| 2013 | 6 |
| 2014 | 5 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 13 |
| 2021 | 11 |
| 2022 | 6 |
| 2023 | 10 |
| 2024 | 4 |
| 2025 | 5 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 58 |
| Unknown status | 15 |
| Recruiting | 9 |
| Terminated | 6 |
| Active, not recruiting | 3 |
| Not yet recruiting | 3 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hamad Medical Corporation | 26 |
| Weill Medical College of Cornell University | 13 |
| AstraZeneca | 12 |
| Bayer | 6 |
| Sidra Medicine | 5 |
| Weill Cornell Medical College in Qatar | 5 |
| Hoffmann-La Roche | 4 |
| Aspetar | 2 |
| Mariah Arif | 2 |
| Medipol University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 8 |
| Diabetes Mellitus | 7 |
| COVID-19 | 6 |
| Asthma | 5 |
| Breast Neoplasms | 4 |
| Cardiovascular Diseases | 4 |
| Obesity | 4 |
| Acute Kidney Injury | 3 |
| Diabetes Mellitus, Type 1 | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
Trials
Showing 51 to 75 of 97. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.